Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 13, 2023

SELL
$54.2 - $71.67 $421,188 - $556,947
-7,771 Reduced 49.42%
7,952 $520,000
Q2 2023

Jul 18, 2023

BUY
$56.23 - $71.17 $884,104 - $1.12 Million
15,723 New
15,723 $914,000
Q2 2022

Aug 23, 2022

SELL
$52.13 - $93.81 $517,598 - $931,439
-9,929 Closed
0 $0
Q1 2022

Apr 29, 2022

SELL
$64.92 - $99.47 $114,973 - $176,161
-1,771 Reduced 15.14%
9,929 $900,000
Q4 2021

Feb 14, 2022

SELL
$76.51 - $93.96 $673,288 - $826,848
-8,800 Reduced 42.93%
11,700 $1.07 Million
Q3 2021

Nov 08, 2021

SELL
$71.29 - $95.99 $64,161 - $86,391
-900 Reduced 4.21%
20,500 $1.66 Million
Q2 2021

Jan 28, 2022

BUY
$79.62 - $114.85 $1.7 Million - $2.46 Million
21,400 New
21,400 $2 Million

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Summit Global Investments Portfolio

Follow Summit Global Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.